Researchers at Baylor report that CS18, a TopBP1-targeting compound, can weaken tumor survival mechanisms, enhance existing drugs and reverse resistance in preclinical models.
A small stem cell trial showed a 94% drop in fragility fractures; new GLP-1 and dual-agonist data shift the obesity landscape; regulators, courts, and insurers weigh in on testosterone and GLP-1s.
A study presented at an ophthalmology meeting found Demodex mites on the lashes of nearly all sampled women who regularly use eyelash extensions, highlighting the need for regular eyelid hygiene and awareness of potential eyelid inflammation.
Yale researchers found that moderate calorie restriction lowers the immune protein C3; blocking C3 in mice reduced age‑related inflammation, suggesting a druggable route to some benefits of dieting.